Pneumococcal conjugate second or third-dose vaccines (PCVc) in Palestine, State of
Palestine, State of: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 99.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Palestine, State of, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Palestine, State of recorded 99.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) in 2025. That is the highest value across all 18 years on record.
That represents a change of unchanged over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Palestine, State of peaked at 99.0% in 2014 and was at its lowest, 0.0%, in 2008.
Palestine, State of ranks 1st of 194 countries on this measure, in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Palestine, State of, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 25.0% | — |
| 2013 | 97.0% | +288.0% |
| 2014 | 99.0% | +2.1% |
| 2015 | 99.0% | +0.0% |
| 2016 | 99.0% | +0.0% |
| 2017 | 99.0% | +0.0% |
| 2018 | 96.0% | -3.0% |
| 2019 | 99.0% | +3.1% |
| 2020 | 98.0% | -1.0% |
| 2021 | 95.0% | -3.1% |
| 2022 | 99.0% | +4.2% |
| 2023 | 87.0% | -12.1% |
| 2024 | 99.0% | +13.8% |
| 2025 | 99.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 71.3% | 0.0% | 99.0% | 10 |
| 2020s | 96.2% | 87.0% | 99.0% | 6 |
Countries ranked near Palestine, State of
More health data for Palestine, State of
- Un projection of annual infant deaths, annual growth rate -1.39 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.4 % change on previous year (2090)
- Heat deaths vs projected death rates 774.2 (2090)
- Un projection of annual infant deaths 284 (2100)
- Population ages 0-14, female, annual growth rate 1.04 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.1842 units per person (2025)
- Population ages 0-14, male, annual growth rate 1.21 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1917 units per person (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Palestine, State of?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Palestine, State of was 99.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Palestine, State of?
- The highest recorded value was 99.0% in 2014.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Palestine, State of?
- The lowest recorded value was 0.0% in 2008.
- How does Palestine, State of rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Palestine, State of ranks 1st out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Palestine, State of?
- Over the last ten years it is unchanged. The long-run trend across the full record is volatile.
- Where does this Palestine, State of data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).